GSK manufacturing review prompts Scynexis to pull Brexafemme, halt trials over contamination concerns
Fierce Pharma
SEPTEMBER 25, 2023
GSK manufacturing review prompts Scynexis to pull Brexafemme, halt trials over contamination concerns esagonowsky Mon, 09/25/2023 - 12:26
Let's personalize your content